Dr. Ildiko Ziegler, Vanessa Research - Qepler Summits And Conferences

Dr. Ildiko Ziegler

Quality Assurance Manager
Vanessa Research
Hungary
New research and comprehensive resources for patients with microvillus inclusion disease. At Vanessa Research we have patented and will soon begin clinical trials of a drug that has been developed to treat MVID – a treatment that will eliminate life-threatening diarrhea by encouraging immature cells in the intestine to grow normally and restore the absorption of fluids and nutrients.

Dr. Ildiko Ziegler has been a professional at Gedeon Richter for 15 years and leading different projects in her field for 5 years.

She has been a distinguished validation expert since Jan 2014, specialised for cleaning validation and quality risk assessment in the pharma industry.

Ildiko obtained M.Sc. in chemical engineering at the Budapest University of Technology and Economics (BUTE) in 1996. She recieved licentiate degree at the Luleå University of Technology (Sweden) in 2000.

She defended Ph. D. at the BUTE in 2000 and obtained the Géza Schay Award for the achievments in the field of physical and theoretical chemistry.

Related Sessions:

Highly Potent APIs
Summit 2019

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 20 Feb 2019
  • Berlin, DE
  • Pharma
Day 1: Wednesday, 20 February 2019
BLOCK: PROCESS ROBUSTNESS, SAFETY & EFFICIENCY.
CASE STUDY: Risk-based handling of highly potent APIs: cross-contamination and transportation parameters.
  • Guidelines regarding Quality Risk Management
  • Case study 1: technical aspects and complexity in cross contamination risk analysis
  • Case study 2: temperature deviation during transportation
View Details

2nd Annual Highly Potent APIs
Summit 2020

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 19 Feb 2020
  • Prague, CZ
  • Pharma
Day 2: Thursday, 20 February 2020
CASE STUDY: Mitigation of cross contamination risk in pharmaceutical production.
  • Guidelines regarding Pharmaceutical Quality Risk Management
  • Technical aspects and complexity in cross contamination risk analysis
  • Case studies
View Details